[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Seasonal Affective Disorder Market 2023 by Company, Regions, Type and Application, Forecast to 2029

January 2023 | 86 pages | ID: G6E75F8850AEEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Seasonal Affective Disorder (SAD) is a type of depression that occurs during a certain time of the year. This disorder is related to changes in seasons, mostly occurs in winter but some people may have this disorder in summers as well. Seasonal affective disorder is most common in women, people between the ages of 15 to 55, and the people who live far from the equator where winter daylight hours are too short. Some major symptoms of this disorder are hopelessness, increased appetite, weight gain, loss of the ability to concentrate, social withdrawal etc. There are some risk factors associated with this disorder such as major depressive disorder, Bipolar I disorder, Bipolar II disorder, and others.

According to our (Global Info Research) latest study, the global Seasonal Affective Disorder market size was valued at USD 546.4 million in 2022 and is forecast to a readjusted size of USD 639.7 million by 2029 with a CAGR of 2.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The Americas hold the largest share in the global Seasonal affective disorder market. North America dominates the market in this region. Approximately 5% of the US population is suffering from seasonal depression Some other factors such as changing lifestyle plays an important role in market growth. South America market is also growing significantly, especially growth is higher in countries such as Brazil due to increasing awareness about various mental disorders.

This report is a detailed and comprehensive analysis for global Seasonal Affective Disorder market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Seasonal Affective Disorder market size and forecasts, in consumption value ($ Million), 2018-2029

Global Seasonal Affective Disorder market size and forecasts by region and country, in consumption value ($ Million), 2018-2029

Global Seasonal Affective Disorder market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029

Global Seasonal Affective Disorder market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Seasonal Affective Disorder

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Seasonal Affective Disorder market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie Inc. (US), Allergan (Republic of Ireland), Bayer AG (Germany), Bristol-Myers Squibb Company (US) and F. Hoffmann-La Roche Ltd. (Switzerland), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Seasonal Affective Disorder market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
  • Light Therapy
  • Medications
  • Others
Market segment by Application
  • Hospital
  • Clinic
  • Household
  • Other
Market segment by players, this report covers
  • AbbVie Inc. (US)
  • Allergan (Republic of Ireland)
  • Bayer AG (Germany)
  • Bristol-Myers Squibb Company (US)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Henry Schein(US)
  • Pfizer Inc. (US)
Market segment by regions, regional analysis covers
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Seasonal Affective Disorder product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Seasonal Affective Disorder, with revenue, gross margin and global market share of Seasonal Affective Disorder from 2018 to 2023.

Chapter 3, the Seasonal Affective Disorder competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Seasonal Affective Disorder market forecast, by regions, type and application, with consumption value, from 2024 to 2029.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War

Chapter 12, the key raw materials and key suppliers, and industry chain of Seasonal Affective Disorder.

Chapter 13, to describe Seasonal Affective Disorder research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Seasonal Affective Disorder
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Seasonal Affective Disorder by Type
  1.3.1 Overview: Global Seasonal Affective Disorder Market Size by Type: 2018 Versus 2022 Versus 2029
  1.3.2 Global Seasonal Affective Disorder Consumption Value Market Share by Type in 2022
  1.3.3 Light Therapy
  1.3.4 Medications
  1.3.5 Others
1.4 Global Seasonal Affective Disorder Market by Application
  1.4.1 Overview: Global Seasonal Affective Disorder Market Size by Application: 2018 Versus 2022 Versus 2029
  1.4.2 Hospital
  1.4.3 Clinic
  1.4.4 Household
  1.4.5 Other
1.5 Global Seasonal Affective Disorder Market Size & Forecast
1.6 Global Seasonal Affective Disorder Market Size and Forecast by Region
  1.6.1 Global Seasonal Affective Disorder Market Size by Region: 2018 VS 2022 VS 2029
  1.6.2 Global Seasonal Affective Disorder Market Size by Region, (2018-2029)
  1.6.3 North America Seasonal Affective Disorder Market Size and Prospect (2018-2029)
  1.6.4 Europe Seasonal Affective Disorder Market Size and Prospect (2018-2029)
  1.6.5 Asia-Pacific Seasonal Affective Disorder Market Size and Prospect (2018-2029)
  1.6.6 South America Seasonal Affective Disorder Market Size and Prospect (2018-2029)
  1.6.7 Middle East and Africa Seasonal Affective Disorder Market Size and Prospect (2018-2029)

2 COMPANY PROFILES

2.1 AbbVie Inc. (US)
  2.1.1 AbbVie Inc. (US) Details
  2.1.2 AbbVie Inc. (US) Major Business
  2.1.3 AbbVie Inc. (US) Seasonal Affective Disorder Product and Solutions
  2.1.4 AbbVie Inc. (US) Seasonal Affective Disorder Revenue, Gross Margin and Market Share (2018-2023)
  2.1.5 AbbVie Inc. (US) Recent Developments and Future Plans
2.2 Allergan (Republic of Ireland)
  2.2.1 Allergan (Republic of Ireland) Details
  2.2.2 Allergan (Republic of Ireland) Major Business
  2.2.3 Allergan (Republic of Ireland) Seasonal Affective Disorder Product and Solutions
  2.2.4 Allergan (Republic of Ireland) Seasonal Affective Disorder Revenue, Gross Margin and Market Share (2018-2023)
  2.2.5 Allergan (Republic of Ireland) Recent Developments and Future Plans
2.3 Bayer AG (Germany)
  2.3.1 Bayer AG (Germany) Details
  2.3.2 Bayer AG (Germany) Major Business
  2.3.3 Bayer AG (Germany) Seasonal Affective Disorder Product and Solutions
  2.3.4 Bayer AG (Germany) Seasonal Affective Disorder Revenue, Gross Margin and Market Share (2018-2023)
  2.3.5 Bayer AG (Germany) Recent Developments and Future Plans
2.4 Bristol-Myers Squibb Company (US)
  2.4.1 Bristol-Myers Squibb Company (US) Details
  2.4.2 Bristol-Myers Squibb Company (US) Major Business
  2.4.3 Bristol-Myers Squibb Company (US) Seasonal Affective Disorder Product and Solutions
  2.4.4 Bristol-Myers Squibb Company (US) Seasonal Affective Disorder Revenue, Gross Margin and Market Share (2018-2023)
  2.4.5 Bristol-Myers Squibb Company (US) Recent Developments and Future Plans
2.5 F. Hoffmann-La Roche Ltd. (Switzerland)
  2.5.1 F. Hoffmann-La Roche Ltd. (Switzerland) Details
  2.5.2 F. Hoffmann-La Roche Ltd. (Switzerland) Major Business
  2.5.3 F. Hoffmann-La Roche Ltd. (Switzerland) Seasonal Affective Disorder Product and Solutions
  2.5.4 F. Hoffmann-La Roche Ltd. (Switzerland) Seasonal Affective Disorder Revenue, Gross Margin and Market Share (2018-2023)
  2.5.5 F. Hoffmann-La Roche Ltd. (Switzerland) Recent Developments and Future Plans
2.6 Henry Schein(US)
  2.6.1 Henry Schein(US) Details
  2.6.2 Henry Schein(US) Major Business
  2.6.3 Henry Schein(US) Seasonal Affective Disorder Product and Solutions
  2.6.4 Henry Schein(US) Seasonal Affective Disorder Revenue, Gross Margin and Market Share (2018-2023)
  2.6.5 Henry Schein(US) Recent Developments and Future Plans
2.7 Pfizer Inc. (US)
  2.7.1 Pfizer Inc. (US) Details
  2.7.2 Pfizer Inc. (US) Major Business
  2.7.3 Pfizer Inc. (US) Seasonal Affective Disorder Product and Solutions
  2.7.4 Pfizer Inc. (US) Seasonal Affective Disorder Revenue, Gross Margin and Market Share (2018-2023)
  2.7.5 Pfizer Inc. (US) Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Seasonal Affective Disorder Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
  3.2.1 Market Share of Seasonal Affective Disorder by Company Revenue
  3.2.2 Top 3 Seasonal Affective Disorder Players Market Share in 2022
  3.2.3 Top 6 Seasonal Affective Disorder Players Market Share in 2022
3.3 Seasonal Affective Disorder Market: Overall Company Footprint Analysis
  3.3.1 Seasonal Affective Disorder Market: Region Footprint
  3.3.2 Seasonal Affective Disorder Market: Company Product Type Footprint
  3.3.3 Seasonal Affective Disorder Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Seasonal Affective Disorder Consumption Value and Market Share by Type (2018-2023)
4.2 Global Seasonal Affective Disorder Market Forecast by Type (2024-2029)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Seasonal Affective Disorder Consumption Value Market Share by Application (2018-2023)
5.2 Global Seasonal Affective Disorder Market Forecast by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Seasonal Affective Disorder Consumption Value by Type (2018-2029)
6.2 North America Seasonal Affective Disorder Consumption Value by Application (2018-2029)
6.3 North America Seasonal Affective Disorder Market Size by Country
  6.3.1 North America Seasonal Affective Disorder Consumption Value by Country (2018-2029)
  6.3.2 United States Seasonal Affective Disorder Market Size and Forecast (2018-2029)
  6.3.3 Canada Seasonal Affective Disorder Market Size and Forecast (2018-2029)
  6.3.4 Mexico Seasonal Affective Disorder Market Size and Forecast (2018-2029)

7 EUROPE

7.1 Europe Seasonal Affective Disorder Consumption Value by Type (2018-2029)
7.2 Europe Seasonal Affective Disorder Consumption Value by Application (2018-2029)
7.3 Europe Seasonal Affective Disorder Market Size by Country
  7.3.1 Europe Seasonal Affective Disorder Consumption Value by Country (2018-2029)
  7.3.2 Germany Seasonal Affective Disorder Market Size and Forecast (2018-2029)
  7.3.3 France Seasonal Affective Disorder Market Size and Forecast (2018-2029)
  7.3.4 United Kingdom Seasonal Affective Disorder Market Size and Forecast (2018-2029)
  7.3.5 Russia Seasonal Affective Disorder Market Size and Forecast (2018-2029)
  7.3.6 Italy Seasonal Affective Disorder Market Size and Forecast (2018-2029)

8 ASIA-PACIFIC

8.1 Asia-Pacific Seasonal Affective Disorder Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Seasonal Affective Disorder Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Seasonal Affective Disorder Market Size by Region
  8.3.1 Asia-Pacific Seasonal Affective Disorder Consumption Value by Region (2018-2029)
  8.3.2 China Seasonal Affective Disorder Market Size and Forecast (2018-2029)
  8.3.3 Japan Seasonal Affective Disorder Market Size and Forecast (2018-2029)
  8.3.4 South Korea Seasonal Affective Disorder Market Size and Forecast (2018-2029)
  8.3.5 India Seasonal Affective Disorder Market Size and Forecast (2018-2029)
  8.3.6 Southeast Asia Seasonal Affective Disorder Market Size and Forecast (2018-2029)
  8.3.7 Australia Seasonal Affective Disorder Market Size and Forecast (2018-2029)

9 SOUTH AMERICA

9.1 South America Seasonal Affective Disorder Consumption Value by Type (2018-2029)
9.2 South America Seasonal Affective Disorder Consumption Value by Application (2018-2029)
9.3 South America Seasonal Affective Disorder Market Size by Country
  9.3.1 South America Seasonal Affective Disorder Consumption Value by Country (2018-2029)
  9.3.2 Brazil Seasonal Affective Disorder Market Size and Forecast (2018-2029)
  9.3.3 Argentina Seasonal Affective Disorder Market Size and Forecast (2018-2029)

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Seasonal Affective Disorder Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Seasonal Affective Disorder Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Seasonal Affective Disorder Market Size by Country
  10.3.1 Middle East & Africa Seasonal Affective Disorder Consumption Value by Country (2018-2029)
  10.3.2 Turkey Seasonal Affective Disorder Market Size and Forecast (2018-2029)
  10.3.3 Saudi Arabia Seasonal Affective Disorder Market Size and Forecast (2018-2029)
  10.3.4 UAE Seasonal Affective Disorder Market Size and Forecast (2018-2029)

11 MARKET DYNAMICS

11.1 Seasonal Affective Disorder Market Drivers
11.2 Seasonal Affective Disorder Market Restraints
11.3 Seasonal Affective Disorder Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
  11.5.1 Influence of COVID-19
  11.5.2 Influence of Russia-Ukraine War

12 INDUSTRY CHAIN ANALYSIS

12.1 Seasonal Affective Disorder Industry Chain
12.2 Seasonal Affective Disorder Upstream Analysis
12.3 Seasonal Affective Disorder Midstream Analysis
12.4 Seasonal Affective Disorder Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

LIST OF TABLES

Table 1. Global Seasonal Affective Disorder Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Seasonal Affective Disorder Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Seasonal Affective Disorder Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Seasonal Affective Disorder Consumption Value by Region (2024-2029) & (USD Million)
Table 5. AbbVie Inc. (US) Company Information, Head Office, and Major Competitors
Table 6. AbbVie Inc. (US) Major Business
Table 7. AbbVie Inc. (US) Seasonal Affective Disorder Product and Solutions
Table 8. AbbVie Inc. (US) Seasonal Affective Disorder Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. AbbVie Inc. (US) Recent Developments and Future Plans
Table 10. Allergan (Republic of Ireland) Company Information, Head Office, and Major Competitors
Table 11. Allergan (Republic of Ireland) Major Business
Table 12. Allergan (Republic of Ireland) Seasonal Affective Disorder Product and Solutions
Table 13. Allergan (Republic of Ireland) Seasonal Affective Disorder Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Allergan (Republic of Ireland) Recent Developments and Future Plans
Table 15. Bayer AG (Germany) Company Information, Head Office, and Major Competitors
Table 16. Bayer AG (Germany) Major Business
Table 17. Bayer AG (Germany) Seasonal Affective Disorder Product and Solutions
Table 18. Bayer AG (Germany) Seasonal Affective Disorder Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Bayer AG (Germany) Recent Developments and Future Plans
Table 20. Bristol-Myers Squibb Company (US) Company Information, Head Office, and Major Competitors
Table 21. Bristol-Myers Squibb Company (US) Major Business
Table 22. Bristol-Myers Squibb Company (US) Seasonal Affective Disorder Product and Solutions
Table 23. Bristol-Myers Squibb Company (US) Seasonal Affective Disorder Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Bristol-Myers Squibb Company (US) Recent Developments and Future Plans
Table 25. F. Hoffmann-La Roche Ltd. (Switzerland) Company Information, Head Office, and Major Competitors
Table 26. F. Hoffmann-La Roche Ltd. (Switzerland) Major Business
Table 27. F. Hoffmann-La Roche Ltd. (Switzerland) Seasonal Affective Disorder Product and Solutions
Table 28. F. Hoffmann-La Roche Ltd. (Switzerland) Seasonal Affective Disorder Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. F. Hoffmann-La Roche Ltd. (Switzerland) Recent Developments and Future Plans
Table 30. Henry Schein(US) Company Information, Head Office, and Major Competitors
Table 31. Henry Schein(US) Major Business
Table 32. Henry Schein(US) Seasonal Affective Disorder Product and Solutions
Table 33. Henry Schein(US) Seasonal Affective Disorder Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Henry Schein(US) Recent Developments and Future Plans
Table 35. Pfizer Inc. (US) Company Information, Head Office, and Major Competitors
Table 36. Pfizer Inc. (US) Major Business
Table 37. Pfizer Inc. (US) Seasonal Affective Disorder Product and Solutions
Table 38. Pfizer Inc. (US) Seasonal Affective Disorder Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Pfizer Inc. (US) Recent Developments and Future Plans
Table 40. Global Seasonal Affective Disorder Revenue (USD Million) by Players (2018-2023)
Table 41. Global Seasonal Affective Disorder Revenue Share by Players (2018-2023)
Table 42. Breakdown of Seasonal Affective Disorder by Company Type (Tier 1, Tier 2, and Tier 3)
Table 43. Market Position of Players in Seasonal Affective Disorder, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 44. Head Office of Key Seasonal Affective Disorder Players
Table 45. Seasonal Affective Disorder Market: Company Product Type Footprint
Table 46. Seasonal Affective Disorder Market: Company Product Application Footprint
Table 47. Seasonal Affective Disorder New Market Entrants and Barriers to Market Entry
Table 48. Seasonal Affective Disorder Mergers, Acquisition, Agreements, and Collaborations
Table 49. Global Seasonal Affective Disorder Consumption Value (USD Million) by Type (2018-2023)
Table 50. Global Seasonal Affective Disorder Consumption Value Share by Type (2018-2023)
Table 51. Global Seasonal Affective Disorder Consumption Value Forecast by Type (2024-2029)
Table 52. Global Seasonal Affective Disorder Consumption Value by Application (2018-2023)
Table 53. Global Seasonal Affective Disorder Consumption Value Forecast by Application (2024-2029)
Table 54. North America Seasonal Affective Disorder Consumption Value by Type (2018-2023) & (USD Million)
Table 55. North America Seasonal Affective Disorder Consumption Value by Type (2024-2029) & (USD Million)
Table 56. North America Seasonal Affective Disorder Consumption Value by Application (2018-2023) & (USD Million)
Table 57. North America Seasonal Affective Disorder Consumption Value by Application (2024-2029) & (USD Million)
Table 58. North America Seasonal Affective Disorder Consumption Value by Country (2018-2023) & (USD Million)
Table 59. North America Seasonal Affective Disorder Consumption Value by Country (2024-2029) & (USD Million)
Table 60. Europe Seasonal Affective Disorder Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Europe Seasonal Affective Disorder Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Europe Seasonal Affective Disorder Consumption Value by Application (2018-2023) & (USD Million)
Table 63. Europe Seasonal Affective Disorder Consumption Value by Application (2024-2029) & (USD Million)
Table 64. Europe Seasonal Affective Disorder Consumption Value by Country (2018-2023) & (USD Million)
Table 65. Europe Seasonal Affective Disorder Consumption Value by Country (2024-2029) & (USD Million)
Table 66. Asia-Pacific Seasonal Affective Disorder Consumption Value by Type (2018-2023) & (USD Million)
Table 67. Asia-Pacific Seasonal Affective Disorder Consumption Value by Type (2024-2029) & (USD Million)
Table 68. Asia-Pacific Seasonal Affective Disorder Consumption Value by Application (2018-2023) & (USD Million)
Table 69. Asia-Pacific Seasonal Affective Disorder Consumption Value by Application (2024-2029) & (USD Million)
Table 70. Asia-Pacific Seasonal Affective Disorder Consumption Value by Region (2018-2023) & (USD Million)
Table 71. Asia-Pacific Seasonal Affective Disorder Consumption Value by Region (2024-2029) & (USD Million)
Table 72. South America Seasonal Affective Disorder Consumption Value by Type (2018-2023) & (USD Million)
Table 73. South America Seasonal Affective Disorder Consumption Value by Type (2024-2029) & (USD Million)
Table 74. South America Seasonal Affective Disorder Consumption Value by Application (2018-2023) & (USD Million)
Table 75. South America Seasonal Affective Disorder Consumption Value by Application (2024-2029) & (USD Million)
Table 76. South America Seasonal Affective Disorder Consumption Value by Country (2018-2023) & (USD Million)
Table 77. South America Seasonal Affective Disorder Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Middle East & Africa Seasonal Affective Disorder Consumption Value by Type (2018-2023) & (USD Million)
Table 79. Middle East & Africa Seasonal Affective Disorder Consumption Value by Type (2024-2029) & (USD Million)
Table 80. Middle East & Africa Seasonal Affective Disorder Consumption Value by Application (2018-2023) & (USD Million)
Table 81. Middle East & Africa Seasonal Affective Disorder Consumption Value by Application (2024-2029) & (USD Million)
Table 82. Middle East & Africa Seasonal Affective Disorder Consumption Value by Country (2018-2023) & (USD Million)
Table 83. Middle East & Africa Seasonal Affective Disorder Consumption Value by Country (2024-2029) & (USD Million)
Table 84. Seasonal Affective Disorder Raw Material
Table 85. Key Suppliers of Seasonal Affective Disorder Raw Materials

LIST OF FIGURES

Figure 1. Seasonal Affective Disorder Picture
Figure 2. Global Seasonal Affective Disorder Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Seasonal Affective Disorder Consumption Value Market Share by Type in 2022
Figure 4. Light Therapy
Figure 5. Medications
Figure 6. Others
Figure 7. Global Seasonal Affective Disorder Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Seasonal Affective Disorder Consumption Value Market Share by Application in 2022
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Household Picture
Figure 12. Other Picture
Figure 13. Global Seasonal Affective Disorder Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Seasonal Affective Disorder Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Seasonal Affective Disorder Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Seasonal Affective Disorder Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Seasonal Affective Disorder Consumption Value Market Share by Region in 2022
Figure 18. North America Seasonal Affective Disorder Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Seasonal Affective Disorder Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Seasonal Affective Disorder Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Seasonal Affective Disorder Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Seasonal Affective Disorder Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Seasonal Affective Disorder Revenue Share by Players in 2022
Figure 24. Seasonal Affective Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Seasonal Affective Disorder Market Share in 2022
Figure 26. Global Top 6 Players Seasonal Affective Disorder Market Share in 2022
Figure 27. Global Seasonal Affective Disorder Consumption Value Share by Type (2018-2023)
Figure 28. Global Seasonal Affective Disorder Market Share Forecast by Type (2024-2029)
Figure 29. Global Seasonal Affective Disorder Consumption Value Share by Application (2018-2023)
Figure 30. Global Seasonal Affective Disorder Market Share Forecast by Application (2024-2029)
Figure 31. North America Seasonal Affective Disorder Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Seasonal Affective Disorder Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Seasonal Affective Disorder Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Seasonal Affective Disorder Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Seasonal Affective Disorder Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Seasonal Affective Disorder Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Seasonal Affective Disorder Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Seasonal Affective Disorder Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Seasonal Affective Disorder Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Seasonal Affective Disorder Consumption Value (2018-2029) & (USD Million)
Figure 41. France Seasonal Affective Disorder Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Seasonal Affective Disorder Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Seasonal Affective Disorder Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Seasonal Affective Disorder Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Seasonal Affective Disorder Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Seasonal Affective Disorder Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Seasonal Affective Disorder Consumption Value Market Share by Region (2018-2029)
Figure 48. China Seasonal Affective Disorder Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Seasonal Affective Disorder Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Seasonal Affective Disorder Consumption Value (2018-2029) & (USD Million)
Figure 51. India Seasonal Affective Disorder Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Seasonal Affective Disorder Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Seasonal Affective Disorder Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Seasonal Affective Disorder Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Seasonal Affective Disorder Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Seasonal Affective Disorder Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Seasonal Affective Disorder Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Seasonal Affective Disorder Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Seasonal Affective Disorder Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Seasonal Affective Disorder Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Seasonal Affective Disorder Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Seasonal Affective Disorder Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Seasonal Affective Disorder Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Seasonal Affective Disorder Consumption Value (2018-2029) & (USD Million)
Figure 65. Seasonal Affective Disorder Market Drivers
Figure 66. Seasonal Affective Disorder Market Restraints
Figure 67. Seasonal Affective Disorder Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Seasonal Affective Disorder in 2022
Figure 70. Manufacturing Process Analysis of Seasonal Affective Disorder
Figure 71. Seasonal Affective Disorder Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source


More Publications